ICU Medical Inc (ICUI)
172.00
+1.18
(+0.69%)
USD |
NASDAQ |
Nov 04, 16:00
172.02
+0.02
(+0.01%)
Pre-Market: 20:00
ICU Medical Research and Development Expense (Annual): 85.34M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 85.34M |
| December 31, 2022 | 92.98M |
| December 31, 2021 | 47.50M |
| December 31, 2020 | 42.95M |
| December 31, 2019 | 48.61M |
| December 31, 2018 | 52.87M |
| December 31, 2017 | 51.25M |
| December 31, 2016 | 12.96M |
| December 31, 2015 | 15.71M |
| December 31, 2014 | 18.33M |
| December 31, 2013 | 12.41M |
| December 31, 2012 | 10.63M |
| December 31, 2011 | 8.588M |
| December 31, 2010 | 4.678M |
| Date | Value |
|---|---|
| December 31, 2009 | 2.645M |
| December 31, 2008 | 4.822M |
| December 31, 2007 | 8.111M |
| December 31, 2006 | 7.659M |
| December 31, 2005 | 4.817M |
| December 31, 2004 | 3.376M |
| December 31, 2003 | 1.757M |
| December 31, 2002 | 1.472M |
| December 31, 2001 | 1.188M |
| December 31, 2000 | 1.48M |
| December 31, 1999 | 1.20M |
| December 31, 1998 | 1.00M |
| December 31, 1997 | 1.30M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
42.95M
Minimum
2020
92.98M
Maximum
2022
63.48M
Average
48.61M
Median
2019
Research and Development Expense (Annual) Benchmarks
| Baxter International Inc | 667.00M |
| Becton Dickinson & Co | 1.237B |
| Outset Medical Inc | 57.31M |
| Perspective Therapeutics Inc | 21.31M |
| Xtant Medical Holdings Inc | 1.336M |